{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,16]],"date-time":"2025-10-16T13:35:52Z","timestamp":1760621752092},"reference-count":22,"publisher":"Elsevier BV","issue":"22","license":[{"start":{"date-parts":[[2008,5,1]],"date-time":"2008-05-01T00:00:00Z","timestamp":1209600000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2008,5]]},"DOI":"10.1016\/j.vaccine.2008.03.017","type":"journal-article","created":{"date-parts":[[2008,4,2]],"date-time":"2008-04-02T13:21:26Z","timestamp":1207142486000},"page":"2746-2752","source":"Crossref","is-referenced-by-count":12,"title":["The Intensive Vaccines Monitoring Programme (IVMP): An electronic system to monitor vaccine safety in New Zealand"],"prefix":"10.1016","volume":"26","author":[{"given":"Michael V.","family":"Tatley","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Desire\u00e9 L.","family":"Kunac","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anne","family":"McNicholas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lifeng","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Suzie","family":"Ballantyne","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Janelle","family":"Ashton","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul","family":"Stehr-Green","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yvonne","family":"Galloway","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stewart","family":"Reid","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2008.03.017_bib1","unstructured":"Martin D. The epidemiology of meningococcal disease in New Zealand in 2004. Report prepared for the Ministry of Health by the Institute of Environmental Science and Research Limited. Ministry of Health. Available at: http:\/\/www.moh.govt.nz\/moh.nsf\/238fd5fb4fd051844c256669006aed57\/47914a3170b2449bcc2570290010e66c?OpenDocument Accessed 17 October 2007."},{"issue":"5","key":"10.1016\/j.vaccine.2008.03.017_bib2","doi-asserted-by":"crossref","first-page":"S13","DOI":"10.1046\/j.1440-1754.2001.00722.x","article-title":"A 10-year serogroup B meningococcal disease epidemic in New Zealand: descriptive epidemiology, 1991\u20132000","volume":"37","author":"Baker","year":"2001","journal-title":"J Paediatr Child Health"},{"issue":"17\/18","key":"10.1016\/j.vaccine.2008.03.017_bib3","doi-asserted-by":"crossref","first-page":"2191","DOI":"10.1016\/j.vaccine.2005.01.063","article-title":"MeNZB: a safe and highly immunogenic tailor-made vaccine against the New Zealand Neisseria meningitidis serogroup B disease epidemic strain","volume":"23","author":"Oster","year":"2005","journal-title":"Vaccine"},{"issue":"1200","key":"10.1016\/j.vaccine.2008.03.017_bib4","first-page":"U1015","article-title":"The New Zealand Meningococcal Vaccine Strategy: a tailor-made vaccine to combat a devastating epidemic","volume":"117","author":"Sexton","year":"2004","journal-title":"NZ Med J"},{"key":"10.1016\/j.vaccine.2008.03.017_bib5","unstructured":"IMAC. New Zealand Immunisation Schedule (from 1 July 2004). Immunisation Advisory Centre. Available at: http:\/\/www.immune.org.nz\/site_resources\/Professionals\/Immunisation%20Schedule\/Immunisation_Schedule_July_1_2004.pdf Accessed 15 January 2008."},{"issue":"12 Suppl","key":"10.1016\/j.vaccine.2008.03.017_bib6","doi-asserted-by":"crossref","first-page":"S293","DOI":"10.1097\/01.inf.0000147645.53942.00","article-title":"The strategy to control New Zealand's epidemic of group B meningococcal disease","volume":"23","author":"O\u2019Hallahan","year":"2004","journal-title":"Pediatr Infect Dis J"},{"issue":"2","key":"10.1016\/j.vaccine.2008.03.017_bib7","first-page":"133","article-title":"Adverse events following vaccine or placebo injection in an efficacy trial of an outer membrane vesicle vaccine against group B meningococcal disease in Norwegian secondary schools 1988\u20131991","volume":"14","author":"Aavitsland","year":"1991","journal-title":"NIPH Ann"},{"issue":"9","key":"10.1016\/j.vaccine.2008.03.017_bib8","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1016\/0264-410X(94)00037-N","article-title":"Efficacy, safety, and immunogenicity of a meningococcal group B (15:P1.3) outer membrane protein vaccine in Iquique, Chile. Chilean National Committee for Meningococcal Disease","volume":"13","author":"Boslego","year":"1995","journal-title":"Vaccine"},{"issue":"17\/18","key":"10.1016\/j.vaccine.2008.03.017_bib9","doi-asserted-by":"crossref","first-page":"2202","DOI":"10.1016\/j.vaccine.2005.01.058","article-title":"The concept of \u201ctailor-made\u201d, protein-based, outer membrane vesicle vaccines against meningococcal disease","volume":"23","author":"Holst","year":"2005","journal-title":"Vaccine"},{"issue":"10","key":"10.1016\/j.vaccine.2008.03.017_bib10","doi-asserted-by":"crossref","first-page":"4419","DOI":"10.1128\/IAI.62.10.4419-4424.1994","article-title":"Immune response of Brazilian children to a Neisseria meningitidis serogroup B outer membrane protein vaccine: comparison with efficacy","volume":"62","author":"Milagres","year":"1994","journal-title":"Infect Immun"},{"issue":"16","key":"10.1016\/j.vaccine.2008.03.017_bib11","doi-asserted-by":"crossref","first-page":"1520","DOI":"10.1001\/jama.281.16.1520","article-title":"Immunogenicity of 2 serogroup B outer-membrane protein meningococcal vaccines: a randomized controlled trial in Chile","volume":"281","author":"Tappero","year":"1999","journal-title":"JAMA"},{"issue":"2","key":"10.1016\/j.vaccine.2008.03.017_bib12","first-page":"195","article-title":"Vaccine against group B Neisseria meningitidis: protection trial and mass vaccination results in Cuba","volume":"14","author":"Sierra","year":"1991","journal-title":"NIPH Ann"},{"issue":"8775","key":"10.1016\/j.vaccine.2008.03.017_bib13","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1016\/0140-6736(91)91961-S","article-title":"Effect of outer membrane vesicle vaccine against group B meningococcal disease in Norway","volume":"338","author":"Bjune","year":"1991","journal-title":"Lancet"},{"issue":"17\/18","key":"10.1016\/j.vaccine.2008.03.017_bib14","doi-asserted-by":"crossref","first-page":"2197","DOI":"10.1016\/j.vaccine.2005.01.061","article-title":"From secondary prevention to primary prevention: a unique strategy that gives hope to a country ravaged by meningococcal disease","volume":"23","author":"O\u2019Hallahan","year":"2005","journal-title":"Vaccine"},{"issue":"5","key":"10.1016\/j.vaccine.2008.03.017_bib15","doi-asserted-by":"crossref","first-page":"196","DOI":"10.4161\/hv.3.5.4458","article-title":"Post-marketing safety surveillance of a new group B meningococcal vaccine in New Zealand, 2004\u20132006","volume":"3","author":"McNicholas","year":"2007","journal-title":"Hum Vaccin"},{"issue":"5","key":"10.1016\/j.vaccine.2008.03.017_bib16","doi-asserted-by":"crossref","first-page":"385","DOI":"10.2165\/00002018-200629050-00003","article-title":"Under-reporting of adverse drug reactions: a systematic review","volume":"29","author":"Hazell","year":"2006","journal-title":"Drug Saf"},{"key":"10.1016\/j.vaccine.2008.03.017_bib17","series-title":"Pharmacovigilance","first-page":"317","article-title":"PEM in New Zealand","author":"Harrison-Woolrych","year":"2007"},{"issue":"2","key":"10.1016\/j.vaccine.2008.03.017_bib18","doi-asserted-by":"crossref","first-page":"93","DOI":"10.2165\/00002018-199410020-00001","article-title":"Harmonisation in pharmacovigilance","volume":"10","author":"Edwards","year":"1994","journal-title":"Drug Saf"},{"issue":"6","key":"10.1016\/j.vaccine.2008.03.017_bib19","doi-asserted-by":"crossref","first-page":"374","DOI":"10.2165\/00002018-199717060-00004","article-title":"Causal or casual? The role of causality assessment in pharmacovigilance","volume":"17","author":"Meyboom","year":"1997","journal-title":"Drug Saf"},{"issue":"1","key":"10.1016\/j.vaccine.2008.03.017_bib20","doi-asserted-by":"crossref","first-page":"159","DOI":"10.2307\/2529310","article-title":"The measurement of observer agreement for categorical data","volume":"33","author":"Landis","year":"1977","journal-title":"Biometrics"},{"key":"10.1016\/j.vaccine.2008.03.017_bib21","series-title":"Categorical data analysis using the SAS system","author":"Stokes","year":"1995"},{"key":"10.1016\/j.vaccine.2008.03.017_bib22","unstructured":"CBG Health Research 2006. Evaluation of Meningococcal B Immunisation National Roll Out\u2014Final Report, Prepared for the Ministry of Health. Available at: http:\/\/www.moh.govt.nz\/moh.nsf\/pagesmh\/6374\/$File\/menzb-implementation-evaluation-nov06.pdf Accessed 17 October 2007."}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X08003216?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X08003216?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,9,7]],"date-time":"2021-09-07T01:50:30Z","timestamp":1630979430000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X08003216"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,5]]},"references-count":22,"journal-issue":{"issue":"22","published-print":{"date-parts":[[2008,5]]}},"alternative-id":["S0264410X08003216"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2008.03.017","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2008,5]]}}}